
Keywords: ACS, acute coronary syndrome; BRS, bleeding risk score; CHD, coronary heart disease; CV, cardiovascular; DES, drug eluting stent; GPI, glycoprotein IIbIIIa inhibitor; HPR, high platelet reactivity; LPR, low platelet reactivity; MACE, major adverse cardiac